Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications
The prevalence of overweight and obesity among youth patients with diabetes type 1 is increasing. It is estimated, that even up to 35% of young patients with this type of diabetes, considered so far to be characteristic for slim figure, are overweight or even obese. General increase of obesity in ch...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.890833/full |
_version_ | 1811243829143011328 |
---|---|
author | Sebastian Ciężki Emilia Kurpiewska Artur Bossowski Barbara Głowińska-Olszewska |
author_facet | Sebastian Ciężki Emilia Kurpiewska Artur Bossowski Barbara Głowińska-Olszewska |
author_sort | Sebastian Ciężki |
collection | DOAJ |
description | The prevalence of overweight and obesity among youth patients with diabetes type 1 is increasing. It is estimated, that even up to 35% of young patients with this type of diabetes, considered so far to be characteristic for slim figure, are overweight or even obese. General increase of obesity in children’s population complicates differential diagnosis of the type of diabetes in youths. Coexistence of obesity has clinical implications for all stages of diabetes course. It is confirmed that obesity is the risk factor for autoimmune diabetes, and is connected with the earlier onset of diabetes in predisposed patients. Many diabetic patients with obesity present additional risk factors for macroangiopathy, and are recognised to present metabolic syndrome, insulin resistance, and typical for diabetes type 2 - polycystic ovary syndrome, or non-alcoholic fatty liver disease. The prevalence of obesity rises dramatically in adolescence of diabetic child, more often in girls. It has negative impact on metabolic control, glycaemic variability and insulin demand. The risk for microangiopathic complications increases as well. The treatment is difficult and includes not only insulinotherapy and non-pharmacological trials. Recently treatment of insulin resistance with biguanids, and treatment with typical for type 2 new diabetes drugs like GLP-1 analogues, SGLT-2 receptor inhibitors, or even cases of bariatric surgery also has been reported. |
first_indexed | 2024-04-12T14:15:09Z |
format | Article |
id | doaj.art-37a3cd11a913474185f242b98ba491b6 |
institution | Directory Open Access Journal |
issn | 1664-2392 |
language | English |
last_indexed | 2024-04-12T14:15:09Z |
publishDate | 2022-06-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Endocrinology |
spelling | doaj.art-37a3cd11a913474185f242b98ba491b62022-12-22T03:29:45ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-06-011310.3389/fendo.2022.890833890833Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to ComplicationsSebastian CiężkiEmilia KurpiewskaArtur BossowskiBarbara Głowińska-OlszewskaThe prevalence of overweight and obesity among youth patients with diabetes type 1 is increasing. It is estimated, that even up to 35% of young patients with this type of diabetes, considered so far to be characteristic for slim figure, are overweight or even obese. General increase of obesity in children’s population complicates differential diagnosis of the type of diabetes in youths. Coexistence of obesity has clinical implications for all stages of diabetes course. It is confirmed that obesity is the risk factor for autoimmune diabetes, and is connected with the earlier onset of diabetes in predisposed patients. Many diabetic patients with obesity present additional risk factors for macroangiopathy, and are recognised to present metabolic syndrome, insulin resistance, and typical for diabetes type 2 - polycystic ovary syndrome, or non-alcoholic fatty liver disease. The prevalence of obesity rises dramatically in adolescence of diabetic child, more often in girls. It has negative impact on metabolic control, glycaemic variability and insulin demand. The risk for microangiopathic complications increases as well. The treatment is difficult and includes not only insulinotherapy and non-pharmacological trials. Recently treatment of insulin resistance with biguanids, and treatment with typical for type 2 new diabetes drugs like GLP-1 analogues, SGLT-2 receptor inhibitors, or even cases of bariatric surgery also has been reported.https://www.frontiersin.org/articles/10.3389/fendo.2022.890833/fulldiabetes type 1obesitychildrenpathogenesiscomplicationstreatment |
spellingShingle | Sebastian Ciężki Emilia Kurpiewska Artur Bossowski Barbara Głowińska-Olszewska Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications Frontiers in Endocrinology diabetes type 1 obesity children pathogenesis complications treatment |
title | Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications |
title_full | Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications |
title_fullStr | Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications |
title_full_unstemmed | Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications |
title_short | Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications |
title_sort | multi faceted influence of obesity on type 1 diabetes in children from disease pathogenesis to complications |
topic | diabetes type 1 obesity children pathogenesis complications treatment |
url | https://www.frontiersin.org/articles/10.3389/fendo.2022.890833/full |
work_keys_str_mv | AT sebastianciezki multifacetedinfluenceofobesityontype1diabetesinchildrenfromdiseasepathogenesistocomplications AT emiliakurpiewska multifacetedinfluenceofobesityontype1diabetesinchildrenfromdiseasepathogenesistocomplications AT arturbossowski multifacetedinfluenceofobesityontype1diabetesinchildrenfromdiseasepathogenesistocomplications AT barbaragłowinskaolszewska multifacetedinfluenceofobesityontype1diabetesinchildrenfromdiseasepathogenesistocomplications |